OMI Stock Cash Flow Statements

Owens & Minor Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Owens & Minor Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31

operating activities:
net income	-869,058,000	-24,982,000	-296,116,000	-12,771,000	-31,913,000	-21,886,000	17,784,000	-6,426,000	-28,241,000	-24,418,000	-57,992,000	12,497,000	41,975,000	44,128,000	65,897,000	69,589,000	50,742,000	46,080,000	-55,627,000	-11,324,000	-39,023,000	1,224,000	-10,476,000	-14,096,000	-261,821,000	-565,000	-182,777,000	8,151,000	22,997,000	10,870,000	20,141,000	18,785,000	27,105,000	29,831,000	27,716,000	24,135,000	32,067,000	28,176,000	24,226,000	18,940,000	13,987,000	7,154,000	19,877,000	25,485,000	27,941,000	27,971,000	28,872,000	26,098,000	24,933,000	24,597,000	30,113,000	29,360,000	23,942,000	33,352,000	29,164,000	28,740,000	21,788,000	31,505,000	29,469,000	27,817,000	32,347,000	34,687,000	23,648,000	13,976,000	20,203,000	25,283,000	23,633,000	24,208,000	22,453,000
adjustments to reconcile net income to cash from operating activities:
depreciation and amortization	59,399,000	61,153,000	65,187,000	61,614,000	63,879,000	74,095,000	70,737,000	73,652,000	72,062,000	70,926,000	73,229,000	58,152,000	22,479,000	22,641,000	22,601,000	22,900,000	23,842,000	20,690,000	24,891,000	23,913,000	28,474,000	29,302,000	30,182,000	28,720,000	28,331,000	29,783,000	25,902,000	17,911,000	18,383,000	15,854,000	12,648,000	12,558,000	13,211,000	13,839,000	14,125,000	14,218,000	14,111,000	15,733,000	17,015,000	19,123,000	21,810,000	13,841,000	13,892,000	13,864,000	13,239,000	12,442,000	12,276,000	12,629,000	12,420,000	10,091,000	8,515,000	8,578,000	8,656,000	8,463,000	8,249,000	8,767,000	7,788,000	7,464,000	7,107,000	6,789,000	6,682,000	6,721,000	6,046,000	5,816,000	-1,415,000	7,774,000	7,791,000	7,805,000	7,900,000
goodwill impairment charge
loss on classification to held for sale
share-based compensation expense	8,061,000	6,928,000	7,555,000	5,680,000	6,735,000	6,866,000	5,801,000	5,742,000	5,212,000	6,463,000	5,228,000	4,555,000	5,938,000	6,038,000	7,858,000	5,182,000	4,735,000	7,461,000	3,873,000	3,941,000	3,746,000	3,964,000	3,588,000	4,505,000	5,877,000	4,359,000	3,105,000	3,035,000	3,319,000	2,973,000	3,108,000	2,511,000	3,108,000	2,965,000	3,366,000	2,603,000	3,695,000	2,563,000	2,451,000	2,597,000	2,071,000	1,946,000	1,548,000	2,642,000	1,219,000	1,713,000	1,539,000	1,910,000	853,000	718,000	1,741,000	2,385,000	1,339,000	754,000	560,000	3,021,000	906,000	819,000	1,668,000	2,965,000	1,175,000	1,701,000	1,773,000	2,386,000	1,194,000	1,490,000	2,040,000	2,839,000	1,340,000
deferred income tax benefit	-6,068,000	-6,240,000	-10,996,000	-6,090,000	-5,370,000	-3,659,000	-7,333,000	-9,557,000	-6,167,000	-591,000											-5,413,000	2,608,000	-5,984,000	-8,613,000																				-822,000				-56,000			319,000	-1,465,000				-1,830,000
changes in operating lease right-of-use assets and lease liabilities	-41,000	14,452,000	3,088,000	3,390,000	2,627,000	1,139,000	1,470,000	1,560,000	-2,852,000	-225,000	-569,000	316,000	273,000	364,000	378,000	448,000	-348,000	-299,000	-315,000	-714,000	-1,319,000	-664,000
gain from sale and dispositions of patient service equipment and other fixed assets
changes in operating assets and liabilities:
accounts receivable	30,262,000	111,613,000	-35,201,000	9,093,000	6,702,000	-75,144,000	89,384,000	-13,006,000	84,963,000	5,240,000	-6,316,000	-8,858,000	82,180,000	-27,125,000	-11,337,000	-45,919,000	-14,645,000	-57,327,000	45,096,000	-7,942,000	-10,460,000	97,332,000	-773,000	-22,573,000	62,709,000	-21,246,000	-11,838,000	-18,519,000	-20,896,000	-37,251,000	-43,417,000	1,554,000
inventories
accounts payable	-12,344,000	157,668,000	-99,074,000	-39,110,000	150,445,000	52,926,000	-15,341,000	-5,821,000	29,077,000	23,082,000	-16,772,000	18,075,000	-117,273,000	-6,652,000	108,731,000	18,742,000	57,084,000	119,761,000	-82,348,000	98,743,000	-14,250,000	-149,677,000	48,776,000	-120,480,000	3,981,000	40,938,000	37,782,000	9,478,000	64,160,000	37,552,000	49,576,000	-7,341,000	-15,312,000	-3,968,000	15,959,000	46,751,000	30,577,000	-62,248,000	56,738,000	88,944,000	-106,782,000	-288,000	39,107,000	15,815,000	-46,576,000	-97,456,000	93,208,000	98,198,000	-51,161,000	48,542,000	22,204,000	-38,279,000	41,070,000	27,255,000	-103,909,000	79,642,000	-61,450,000	33,608,000	46,514,000	67,474,000	-67,240,000	-22,478,000	10,632,000	60,331,000	-57,010,000	-39,563,000	1,233,000	81,756,000	-43,080,000
net change in other assets and liabilities	-48,236,000	-76,476,000	25,434,000	24,236,000	20,100,000	-39,617,000	-22,497,000	39,913,000	46,471,000	36,483,000	-46,121,000	-21,478,000	9,033,000	-4,978,000	-1,697,000	-1,666,000	74,395,000	7,172,000	889,000	-77,178,000	35,045,000	37,530,000	48,084,000	-15,858,000	-12,082,000	3,107,000	-43,533,000	28,904,000	7,371,000	25,369,000	-41,038,000	-24,965,000	7,344,000	11,696,000	-18,499,000	-38,100,000	4,287,000	23,119,000	-10,809,000	13,580,000	-28,959,000	35,896,000	-36,686,000	3,921,000	-11,052,000	48,177,000	-98,443,000	28,981,000	11,865,000	-17,039,000	-10,925,000	11,609,000	-6,189,000	4,856,000	-15,225,000	-8,096,000	15,019,000	3,773,000
other	5,062,000	760,000	2,502,000	1,978,000	2,723,000	3,168,000	2,965,000	2,680,000	3,162,000	3,832,000	3,476,000	2,708,000	-5,451,000	16,408,000	1,566,000	2,510,000	12,001,000	5,937,000	-3,888,000	4,034,000	3,013,000	1,572,000	2,070,000	3,678,000	3,205,000	1,539,000	1,021,000	278,000	580,000	348,000	628,000	4,743,000	2,215,000	541,000	242,000	-97,000	705,000	330,000	-125,000	1,321,000	-2,045,000	2,400,000	214,000	-1,292,000	36,000	1,635,000	-2,329,000	-465,000	200,000	-369,000	-210,000	-194,000	909,000	221,000	-61,000	175,000	-4,170,000	8,696,000	146,000	-5,268,000	2,074,000	-7,675,000	4,507,000	8,000	978,000	-204,000	2,326,000	-831,000	16,573,000
cash from operating activities	37,610,000	-35,066,000	71,001,000	27,307,000	116,149,000	-52,962,000	111,765,000	157,435,000	313,112,000	158,398,000	86,961,000	68,521,000	50,341,000	61,430,000	-13,017,000	25,423,000	71,027,000	117,739,000	57,003,000	93,454,000	26,980,000	110,091,000	89,918,000	-60,904,000	-6,920,000	76,256,000	27,980,000	18,273,000	51,129,000	88,141,000	-56,136,000	-26,360,000	43,103,000	101,193,000	-2,257,000	44,895,000	63,559,000	-40,752,000	78,087,000	168,703,000	-84,905,000	7,672,000	-19,730,000	93,202,000		-18,013,000	24,568,000	154,611,000																		44,600,000	-29,479,000	108,442,000	17,797,000
capex	0	25,388,000	-53,448,000	-58,849,000	-37,377,000	23,371,000	-33,983,000	-52,666,000	-46,600,000	18,508,000	-48,815,000	-47,039,000	-14,539,000	-11,816,000	-9,582,000	-5,048,000	-28,746,000	-12,945,000	-3,962,000	-4,771,000	-11,195,000	-10,204,000	-9,346,000	-11,674,000	-12,384,000	-12,673,000	-12,742,000	-7,074,000	-9,650,000	-8,530,000	-6,287,000	-10,146,000	-6,620,000	-4,825,000	-3,574,000	-5,283,000	-5,210,000	-3,312,000	-4,390,000	-7,619,000	-12,255,000	-10,512,000	-18,358,000	-7,299,000		-8,923,000	-8,708,000	-7,513,000																		-9,001,000	-1,738,000	-2,027,000	-6,549,000
free cash flows	37,610,000	-9,678,000	17,553,000	-31,542,000	78,772,000	-29,591,000	77,782,000	104,769,000	266,512,000	176,906,000	38,146,000	21,482,000	35,802,000	49,614,000	-22,599,000	20,375,000	42,281,000	104,794,000	53,041,000	88,683,000	15,785,000	99,887,000	80,572,000	-72,578,000	-19,304,000	63,583,000	15,238,000	11,199,000	41,479,000	79,611,000	-62,423,000	-36,506,000	36,483,000	96,368,000	-5,831,000	39,612,000	58,349,000	-44,064,000	73,697,000	161,084,000	-97,160,000	-2,840,000	-38,088,000	85,903,000		-26,936,000	15,860,000	147,098,000																		35,599,000	-31,217,000	106,415,000	11,248,000
investing activities:
additions to patient service equipment and other fixed assets
proceeds from sale of patient service equipment and other fixed assets
additions to computer software	-1,658,000	-8,977,000	-8,602,000	-3,866,000	-1,418,000	-3,411,000	-5,933,000	-2,860,000	-2,889,000	-5,340,000	-2,619,000	-2,410,000	-2,526,000	-2,128,000	-2,476,000	-1,575,000	-4,067,000	-1,293,000	-2,467,000	-942,000	-2,881,000	-2,417,000																																				-2,438,000	-2,714,000	-2,042,000	-3,232,000	-2,000,000	-4,594,000	-2,717,000	-1,842,000	-1,544,000	-3,133,000	-2,762,000	-3,525,000
cash from investing activities	-52,917,000	-48,200,000	-52,304,000	-27,189,000	-35,170,000	-1,870,000	-38,914,000	-32,672,000	-31,484,000	-34,184,000	-32,771,000	-26,406,000	-21,046,000	-13,925,000	-12,040,000	-6,619,000	-32,757,000	-14,129,000	132,639,000	-5,680,000	-13,965,000	-12,740,000	-11,184,000	-14,008,000	-16,948,000	-35,406,000	-749,315,000	-14,160,000	-13,065,000	-379,858,000	-9,267,000	-14,453,000	-8,480,000	-7,372,000	-6,433,000	-2,461,000	-4,395,000	-10,090,000	-10,472,000	-11,516,000	-265,182,000	-15,228,000	-24,654,000	-12,187,000		-12,506,000	-16,246,000	-14,733,000																		-10,545,000	-4,869,000	-4,783,000	-8,914,000
financing activities:
borrowings under amended receivables financing agreement			179,400,000	619,100,000	462,300,000	205,000,000	0	127,800,000	116,100,000	232,100,000
repayments under amended receivables financing agreement			-179,400,000	-619,100,000	-528,000,000	-139,300,000	0	-127,800,000	-116,100,000	-328,100,000
borrowings under revolving credit facility	853,200,000	776,984,000
repayments under revolving credit facility	-815,700,000	-679,484,000												-21,000,000	26,600,000	-96,500,000
repayments of debt			-32,750,000				-50,504,000	-191,888,000	-51,801,000	-26,500,000	-1,500,000	-1,500,000	0	-30,000,000	0	-523,140,000		-12,394,000	-91,207,000	-166,798,000		-15,912,000	-12,394,000	-12,394,000		-3,125,000	-3,125,000	-3,125,000
repurchase of common stock	-5,153,000	-1,503,000
cash from financing activities	31,699,000	92,778,000	-43,096,000	-199,587,000	-78,240,000	53,320,000	-51,215,000	-182,995,000	-55,631,000	-127,489,000	-63,480,000	-20,048,000	-12,256,000	-52,434,000	15,606,000	-80,394,000	-134,431,000	-73,893,000	-139,656,000	-31,406,000	-40,903,000	-73,241,000	-65,558,000	49,505,000	5,905,000	-31,683,000	748,652,000	-21,803,000	-32,917,000	332,455,000	-8,233,000	-18,499,000	-59,802,000	-23,919,000	-42,156,000	-16,066,000	-21,157,000	-26,944,000	-25,718,000	-50,414,000	-202,209,000	526,098,000	-44,537,000	-792,000		-23,373,000	-21,690,000	-17,440,000																		-21,512,000	36,639,000	-103,147,000	-10,454,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	1,259,000	542,000	-1,309,000	1,090,000	-64,000	-618,000	1,128,000	-711,000	-88,000	284,000	2,267,000	-1,888,000
net increase in cash, cash equivalents and restricted cash	17,651,000	10,054,000	-25,708,000	-198,379,000			22,764,000	-58,943,000	225,909,000	-2,991,000	-7,023,000	20,179,000	15,953,000	-5,665,000	-9,030,000	-63,729,000	-92,973,000	31,026,000	55,460,000	56,306,000
cash, cash equivalents and restricted cash at beginning of period	0	49,382,000	0	0	0	272,924,000	0	0	0	86,185,000		0		0	0	134,506,000		0	0	84,687,000
cash, cash equivalents and restricted cash at end of period	17,651,000	59,436,000	-25,708,000	-198,379,000	2,675,000	270,794,000	22,764,000	-58,943,000	225,909,000	83,194,000		20,179,000		-5,665,000	-9,030,000	70,777,000		31,026,000	55,460,000	140,993,000
supplemental disclosure of cash flow information:
income taxes paid	5,333,000	125,000				2,365,000																				5,920,000	19,453,000	1,197,000		1,948,000	22,144,000	2,825,000		8,429,000	29,539,000	20,028,000		11,167,000	23,033,000	4,509,000		24,460,000	25,519,000	15,161,000		11,203,000	38,824,000	1,540,000		12,001,000	36,912,000	1,201,000		10,369,000	37,548,000	5,439,000		8,901,000	31,048,000	1,153,000		15,059,000	27,336,000	598,000
interest paid	38,358,000	27,487,000	37,269,000	33,459,000	52,608,000	18,211,000	52,168,000	22,454,000	46,089,000	32,536,000		29,472,000	6,682,000	14,267,000	7,513,000	10,255,000	28,690,000	17,431,000	22,409,000	21,431,000	18,943,000	23,287,000	28,679,000	24,504,000		20,465,000	15,187,000	9,661,000		6,923,000	6,845,000	6,183,000		6,510,000	7,287,000	6,226,000		6,935,000	7,336,000	5,924,000		1,015,000	6,863,000	539,000		235,000	6,993,000	698,000		177,000	6,831,000	541,000		-225,000	6,881,000	564,000		16,000	6,516,000	86,000		83,000	6,457,000	154,000
noncash investing activity:
unpaid purchases of patient service equipment and other fixed assets at end of period
gain from sale and dispositions of patient service equipment, property and equipment		-5,353,000
merchandise inventories		-274,589,000	106,205,000	-9,356,000	-87,665,000	-35,412,000	-22,719,000	81,406,000	119,819,000	45,832,000	173,382,000	17,615,000	20,749,000	14,106,000	-208,901,000	-89,393,000	-137,759,000	-54,478,000	67,743,000	39,340,000	-8,100,000	83,675,000	-27,848,000	80,194,000	-86,695,000	16,033,000	35,767,000	-30,556,000	-898,000	30,100,000	-53,457,000	-32,777,000	27,655,000	12,881,000	-33,125,000	15,178,000	-44,388,000	6,527,000	-27,978,000	-3,888,000	6,554,000	-15,308,000	-52,282,000	3,707,000	16,626,000	7,486,000	-52,960,000	21,784,000	14,462,000	-12,218,000	-24,641,000	76,937,000	-47,809,000	-9,379,000	-22,067,000	-20,695,000	10,525,000	-21,218,000	-42,245,000	11,623,000	-8,198,000	28,996,000	5,298,000	-39,624,000	-17,930,000	23,550,000	-24,997,000	-36,779,000	-1,130,000
additions to property and equipment		-55,697,000	-62,834,000	-57,652,000	-44,382,000	-45,997,000	-50,392,000	-47,728,000	-46,600,000	-46,150,000	-48,815,000	-47,039,000	-14,539,000	-11,816,000	-9,582,000	-5,048,000	-28,746,000	-12,945,000	-3,962,000	-4,771,000	-11,195,000	-10,204,000	-9,346,000	-11,674,000	-12,384,000	-12,673,000	-12,742,000	-7,074,000	-9,650,000	-8,530,000	-6,287,000	-10,146,000	-6,620,000	-4,825,000	-3,574,000	-5,283,000	-5,210,000	-3,312,000	-4,390,000	-7,619,000	-12,255,000	-10,512,000	-18,358,000	-7,299,000	-2,975,000	-8,923,000	-8,708,000	-7,513,000	-1,942,000	-2,430,000	-924,000	-4,536,000	-8,135,000	-8,671,000	-4,047,000	-4,128,000	-11,337,000	-4,396,000	-9,640,000	-5,848,000	-5,623,000	-4,703,000	-4,004,000	-5,416,000	-4,903,000	-9,001,000	-1,738,000	-2,027,000	-6,549,000
proceeds from sale of property and equipment		16,884,000			17,488,000	49,538,000	17,929,000	17,916,000	18,423,000	17,306,000	18,663,000	23,874,000		19,000	18,000	4,000	56,000	109,000	36,000	33,000	111,000	-119,000	68,000	271,000	1,432,000	246,000			-117,000	207,000	258,000	315,000	878,000	-68,000	-34,000	4,599,000	24,000	-718,000	787,000	50,000	5,000	106,000	-60,000	105,000	1,031,000	1,952,000	24,000	44,000	61,000	3,122,000	16,000	99,000	2,384,000	2,000	3,000	41,000	1,504,000	810,000	1,579,000	33,000	1,682,000
repayments of term loans					-7,750,000	-4,625,000
unpaid purchases of property and equipment and computer software at end of period		81,085,000	9,386,000	-1,197,000	7,005,000	69,368,000	16,409,000	-4,938,000
gain on extinguishment of debt			790,000
gain from sales and dispositions of property and equipment			-7,023,000
acquisition, net of cash acquired											0	0																																					-5,300,000
proceeds from sales of property and equipment			18,667,000
proceeds from issuance of debt											0	0	0	0	0	574,900,000	5,100,000	0	0	150,000,000					0	0
borrowings under receivables financing agreement
financing costs paid											0	-1,123,000	0	-1,044,000	-1,168,000	-11,700,000	0	0	-4,582,000	-5,785,000	0	0	0	-4,313,000	0	-815,000			0																				0	0
income taxes paid (received)			-2,057,000	2,370,000
benefit for losses on accounts receivable				-1,862,000	143,000	181,000	-927,000	413,000	-379,000	-521,000
loss on extinguishment of debt									279,000	564,000				0	0	40,433,000
gain on sale and dispositions of property and equipment					-12,257,000	-15,619,000	-8,420,000			-8,269,000	-9,258,000
net decrease in cash, cash equivalents and restricted cash						-2,130,000
(gain) loss on extinguishment of debt
changes in operating assets and liabilities, net of acquisitions:
borrowings (repayments) under revolving credit facility, net and receivables financing agreement
cash dividends paid													-183,000	-184,000	-183,000	-181,000	-181,000	-156,000	-156,000	-155,000	-154,000	-154,000	-154,000	-4,764,000	-16,049,000	133,000	-16,210,000	-16,074,000	-15,835,000	-15,840,000	-15,736,000	-15,740,000	-15,580,000	-15,799,000	-15,974,000	-16,029,000	-15,871,000	-15,913,000	-15,933,000	-15,934,000	-15,769,000	-15,771,000	-15,779,000	-15,785,000	-15,144,000	-15,176,000	-15,212,000	-15,199,000	-13,890,000	-13,835,000	-13,955,000	-14,001,000	-12,753,000	-12,660,000	-12,710,000	-12,786,000	-11,260,000	-11,196,000	-11,186,000	-11,138,000	-9,615,000	-9,625,000	-9,607,000	-9,523,000	-8,315,000	-8,272,000	-8,264,000	-8,197,000	-6,947,000
payment for termination of interest rate swaps													0	0	0	-15,434,000
income taxes (received) paid							515,000	3,708,000
borrowings under revolving credit facility, net and receivables financing agreement
(gain) loss on sale and dispositions of property and equipment
borrowings under revolving credit facility, net and receivable financing agreement
income taxes paid, net of refunds										2,405,000		7,786,000			67,132,000	898,000							-1,541,000	-12,388,000
unpaid purchases of property and equipment and software at end of period										64,658,000
impairment charges																				9,080,000
loss on divestiture																	0	0
deferred income tax (benefit) expense													-11,450,000	-6,993,000	-5,428,000	-5,865,000									-28,264,000	-582,000			-45,403,000	800,000				-1,162,000			-9,744,000	651,000			4,002,000	-2,236,000
benefit from losses on accounts receivable											-1,974,000	777,000	1,888,000	3,493,000	7,315,000	8,462,000	1,709,000	1,994,000	2,376,000	5,213,000	3,155,000	3,225,000	2,915,000	3,619,000	3,673,000	2,890,000	1,794,000	1,073,000	1,516,000	1,526,000	235,000	-603,000
proceeds from divestiture																	0	0
proceeds from issuance of common stock
borrowings (repayments) under revolving credit facility, net and accounts receivable securitization program											0
borrowings under amended accounts receivable securitization program											324,600,000	349,900,000
repayments under amended accounts receivable securitization program											-385,600,000	-367,900,000
senior notes make-whole premium paid
deferred income tax expense												1,390,000					-9,453,000	20,748,000	-2,079,000	6,348,000								-1,482,000				-825,000				6,907,000				510,000					-4,711,000	2,647,000			-38,000				13,612,000
loss on sale and dispositions of property and equipment
borrowings under revolving credit facility, net and accounts receivable securitization program
unpaid purchases of property and equipment at end of period
loss on extinguishment and modification of debt
repayments of revolving credit facility
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
income taxes paid (received), net of refunds													15,794,000						3,280,000	2,695,000
proceeds from cash surrender value of life insurance policies																	0	0
effect of exchange rate changes on cash and cash equivalents														-736,000	421,000	-2,139,000	3,188,000	1,309,000	5,474,000	-62,000	-428,000	-2,446,000	2,924,000	-2,721,000	-3,560,000	-2,465,000	3,239,000	800,000	960,000	611,000	3,535,000	991,000	-2,429,000	4,243,000	-526,000	2,935,000	-2,232,000	2,062,000	16,000	-4,489,000	-1,079,000	-422,000	-1,425,000	245,000	1,798,000	-145,000	2,631,000	-1,763,000	1,421,000
repayment of debt
income taxes received, net of payments																	-15,563,000
(repayments) borrowings under revolving credit facility																			-41,700,000	-6,200,000
acquisitions, net of cash acquired																									0	-18,401,000
(repayments) borrowings from revolving credit facility
income taxes (received) paid, net of refunds																					5,887,000
goodwill and intangible asset impairment charges																									274,166,000	0
net increase in cash and cash equivalents																									-21,523,000	6,702,000	30,556,000	-16,890,000	6,107,000			-58,321,000	-27,608,000	74,145,000	-51,372,000	29,303,000	35,775,000	-75,724,000	41,913,000	102,284,000	-553,375,000	518,120,000	-90,346,000	80,468,000	-51,884,000	-54,037,000	-10,737,000	120,675,000	18,221,000	-145,270,000	11,010,000	77,989,000	-60,914,000	37,658,000	-26,656,000	26,637,000	14,143,000	-12,568,000	11,281,000	50,221,000	53,205,000	28,208,000	4,203,000	2,634,000	-17,855,000	12,543,000	2,291,000	512,000
cash and cash equivalents at beginning of period																							0	103,367,000		0	0	104,522,000		0	0	185,488,000		0	0	161,020,000		0	0	56,772,000		0	0	101,905,000		0	0	97,888,000		0	0	135,938,000		0	0	159,213,000		0	0	96,136,000		0	0	7,886,000		8,266,000	0	2,129,000
cash and cash equivalents at end of period																							16,100,000	75,239,000		6,702,000	30,556,000	87,632,000		41,349,000	-70,101,000	127,167,000		74,145,000	-51,372,000	190,323,000		-75,724,000	41,913,000	159,056,000		518,120,000	-90,346,000	182,373,000		-54,037,000	-10,737,000	218,563,000		-145,270,000	11,010,000	213,927,000		37,658,000	-26,656,000	185,850,000		-12,568,000	11,281,000	146,357,000		28,208,000	4,203,000	10,520,000		20,809,000	2,291,000	2,641,000
additions to computer software and intangible assets																								-2,605,000	-5,996,000	-4,578,000	-3,152,000	-7,086,000	-3,298,000	-4,966,000	-3,238,000	-4,622,000	-2,738,000	-2,479,000	-2,825,000	-1,777,000	791,000	-6,060,000	-6,869,000	-3,947,000	-4,396,000	-4,822,000	-6,236,000	-6,930,000	-11,649,000	-5,535,000	-7,562,000	-7,264,000	-9,197,000	-7,237,000	-8,857,000	-3,840,000	-3,299,000	-2,462,000	-2,563,000	-3,010,000
borrowings (repayments) under revolving credit facility																								72,100,000				-300,000
net decrease in cash and cash equivalents																								-28,128,000
proceeds from revolving credit facility																									30,738,000	-26,238,000
repurchases of common stock																													0	-2,000			-22,374,000	-27,805,000	-15,219,000	-5,630,000	-4,179,000	-8,381,000			0	-486,000	-4,448,000	-5,000,000	-3,175,000	-7,404,000	-6,015,000	-2,282,000	-3,750,000	-3,750,000	-3,750,000	-3,750,000	0	-11,038,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
adjustments to reconcile net income to cash from operating activities :
borrowing under revolving credit facility																													-12,600,000
change in bank overdraft																																				8,359,000			351,000	1,179,000				20,578,000
proceeds from debt issuance
benefit from losses on accounts and notes receivable																																	593,000	-189,000	-142,000	115,000	158,000	-223,000	-179,000	220,000	804,000	-690,000	280,000	54,000	608,000	-136,000	208,000	107,000	590,000	144,000	80,000	190,000	1,069,000	349,000	399,000	359,000	135,000	223,000	520,000	930,000	589,000	1,335,000	1,024,000	1,028,000	-12,133,000	5,580,000	5,009,000	5,818,000	8,139,000
loss on early retirement of debt																																									0
accounts and notes receivable																																	-30,267,000	34,759,000	-2,921,000	-26,815,000	32,091,000	-55,380,000	14,266,000	27,356,000	3,653,000	-49,933,000	-1,351,000	29,828,000	-17,942,000	-22,492,000	36,364,000	-34,575,000	35,047,000	-29,125,000	13,686,000	7,553,000	-675,000	-2,992,000	15,780,000	-49,386,000	29,474,000	-33,467,000	9,688,000	18,916,000	10,828,000	-10,628,000	10,647,000	8,408,000	-26,145,000	364,000	-21,912,000	-771,000	38,215,000
proceeds from investment sale
proceeds from (repayment of) revolving credit facility
proceeds from exercise of stock options																																								125,000	0	0	243,000	937,000	531,000	626,000	2,403,000	1,792,000	872,000	353,000	390,000	3,371,000	1,242,000	543,000	3,800,000	3,594,000	1,498,000	134,000	2,621,000	2,981,000	1,365,000	3,058,000	1,430,000	740,000	828,000	914,000	5,401,000	1,825,000	2,242,000
excess tax benefits related to share-based compensation																																	81,000	82,000	348,000	250,000	125,000	64,000	217,000	240,000	68,000	70,000	98,000	346,000	165,000	183,000	343,000	207,000	70,000	63,000	470,000	690,000	177,000	216,000	887,000	874,000	276,000	80,000	807,000	928,000		1,348,000	296,000	662,000		509,000	1,369,000	1,085,000
purchase of noncontrolling interest																																									0	0
repayment of revolving credit facility																																						0	0	-33,700,000
proceeds from sale of investment																																										0	0	1,937,000
long-term debt borrowings
debt issuance costs
adjustments to reconcile net income to cash from operating activities of continuing operations:
proceeds from revolver
pension contributions																																																					134,000	0	0	-543,000
cash from operating activities of continuing operations																																																	48,142,000	27,585,000	40,882,000	101,897,000	38,493,000	64,461,000	-85,954,000	51,419,000	30,092,000	31,403,000	43,618,000	139,470,000	3,860,000	38,047,000	40,313,000	83,100,000
cash from investing activities of continuing operations																																																	-16,378,000	-156,455,000	-9,765,000	-8,277,000	-9,050,000	-11,131,000	-6,607,000	-7,097,000	-12,712,000	-6,024,000	-10,830,000	-7,857,000	-7,173,000	-4,305,000	-8,598,000	-1,139,000
proceeds from termination of interest rate swaps																																																																	0
cash from financing activities of continuing operations																																																	-14,964,000	-17,713,000	-20,107,000	-15,631,000	-90,243,000	-15,647,000	65,943,000	-17,584,000	-3,055,000	-37,409,000	-21,027,000	-80,932,000	56,873,000	-4,062,000	-25,457,000	-156,466,000
discontinued operations:
operating cash flows																																																					-114,000	-25,000	-38,000	-101,000	-182,000	-538,000	-480,000	-460,000	-355,000	-1,472,000	-2,055,000	14,139,000
net cash from discontinued operations																																																					-114,000	-25,000	-38,000	-101,000	-182,000	-538,000	-480,000	-460,000	-355,000	-1,472,000	-2,055,000	77,139,000
adjustments to reconcile net income to cash from operating activities
benefit from lifo reserve																																																	-1,029,000	0	0	5,223,000	2,435,000	0	0	11,265,000	2,655,000	0	163,000	8,270,000	-2,232,000	-11,500,000	0	16,440,000	2,704,000	0	0	10,468,000	924,000
pension expense
proceeds from termination of interest rate swap
income from discontinued operations, net of tax
net cash received related to acquisitions of businesses
payments on revolving credit facility
borrowings on revolving credit facility
investing cash flows																																																													0	0	0	63,000,000
increase in drafts payable																																																						3,900,000							65,300,000	1,672,000			10,682,000	-3,066,000
proceeds from the termination of interest rate swap
decrease in drafts payable																																																								-6,900,000		-25,950,000	-10,050,000	-72,300,000				-1,349,000				-20,700,000
loss on interest rate swaps																																																																	0
net cash received (paid) related to acquisitions of businesses
acquisitions of intangible assets																																																										0
cash received related to acquisition of business																																																														0	0	6,994,000
net change in other current assets and current liabilities																																																												-46,000
supplemental disclosure of cash flow information
loss (income) from discontinued operations
deferred income tax provision
net (payments) borrowings on revolving credit facility
excess tax benefits related to stock-based compensation
income from discontinued operations																																																														0
net change in other current assets and liabilities																																																														16,888,000	-27,389,000	5,949,000		18,419,000	-23,455,000	14,142,000
net payments on revolving credit facility																																																														0	-4,100,000	-146,478,000		-14,708,000
proceeds from the termination of interest rate swaps
(income) income from discontinued operations																																																																8,382,000
operating activities
loss on early extinguishment of debt
investing activities
net cash (paid) received related to acquisitions of businesses
financing activities
net proceeds from issuance of 6.35% senior notes
repayment of 8.5% senior subordinated notes
net borrowings (payments) on revolving credit facility
amortization of direct-response advertising																																																																		1,924,000			2,122,000
deferred direct-response advertising costs																																																																		-3,158,000	-2,903,000	-1,866,000	-1,570,000
acquisition of intangible assets																																																																					-80,000
net cash paid for acquisitions of businesses
amortization of direct-response advertising costs																																																																				1,653,000
net proceeds from (payments on) revolving credit facility																																																																				-76,500,000	48,200,000
net cash related to acquisitions of businesses
net proceeds of issuance of long-term debt
repayment of long-term debt

We provide you with 20 years of cash flow statements for Owens & Minor stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Owens & Minor stock. Explore the full financial landscape of Owens & Minor stock with our expertly curated income statements.

The information provided in this report about Owens & Minor stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.